Cellectis S.A. American Depositary Shares CLLS
$2.75
-3.51%
at last close
Market Cap$276.92 million
P/E Ratio—
Div Yield—
Volume12.7K
52-Week Range
$1.41$5.48
Key Stats
- Today's Range
- $2.67 – $2.85
- 50-Day Range
- $2.59 – $3.80
- 52-Week Range
- $1.41 – $5.48
- Volume
- 13K shs
- Average Volume
- 23K shs
- Market Cap
- $276.92 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 1.26%
- Days to Cover
- 5.35
About Cellectis S.A. American Depositary Shares
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.